SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/11/23 Stryker Corp. 8-K:1,2,9 12/11/23 15:657K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 42K 2: EX-1.1 Underwriting Agreement or Conflict Minerals Report HTML 198K 3: EX-4.2 Instrument Defining the Rights of Security Holders HTML 135K 4: EX-5.1 Opinion of Counsel re: Legality HTML 11K 5: EX-5.2 Opinion of Counsel re: Legality HTML 13K 10: R1 Document and Entity Information HTML 61K 13: XML IDEA XML File -- Filing Summary XML 13K 11: XML XBRL Instance -- d18061d8k_htm XML 29K 12: EXCEL IDEA Workbook of Financial Report Info XLSX 8K 7: EX-101.DEF XBRL Definitions -- syk-20231211_def XML 45K 8: EX-101.LAB XBRL Labels -- syk-20231211_lab XML 75K 9: EX-101.PRE XBRL Presentations -- syk-20231211_pre XML 47K 6: EX-101.SCH XBRL Schema -- syk-20231211 XSD 18K 14: JSON XBRL Instance as JSON Data -- MetaLinks 15± 24K 15: ZIP XBRL Zipped Folder -- 0001193125-23-292590-xbrl Zip 111K
8-K |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i December 11, 2023
STRYKER CORPORATION
(Exact name of registrant as specified in its charter)
i Michigan | i 001-13149 | i 38-1239739 | ||
(State of incorporation) |
(Commission File Number) |
(I.R.S. Employee Identification No.) |
i 2825 Airview Boulevard, i Kalamazoo, i Michigan | i 49002 | |||
(Address of principal executive offices) | (Zip Code) |
i (269) i 385-2600
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading |
Name of each exchange | ||
i Common Stock, $.10 Par Value | i SYK | i New York Stock Exchange | ||
i 0.250% Notes due 2024 | i SYK24A | i New York Stock Exchange | ||
i 2.125% Notes due 2027 | i SYK27 | i New York Stock Exchange | ||
i 0.750% Notes due 2029 | i SYK29 | i New York Stock Exchange | ||
i 2.625% Notes due 2030 | i SYK30 | i New York Stock Exchange | ||
i 1.000% Notes due 2031 | i SYK31 | i New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 1.01 | ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT |
On December 11, 2023, Stryker Corporation (the “Company”) completed a public offering (the “Offering”) of €600,000,000 aggregate principal amount of the Company’s 3.375% Notes due 2028 (the “Notes”).
The Notes were sold pursuant to an Underwriting Agreement, dated December 6, 2023 (the “Underwriting Agreement”), between the Company and Barclays Bank PLC, Goldman Sachs & Co. LLC, Mizuho International plc and Wells Fargo Securities International Limited, as representatives of the underwriters. The Offering was made pursuant to the Company’s Automatic Shelf Registration Statement on Form S-3 (File No. 333-275853) and the Prospectus included therein, filed with the Securities and Exchange Commission on December 1, 2023, and supplemented by the Prospectus Supplement dated December 6, 2023.
The Notes were issued under an Indenture, dated January 15, 2010 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank, National Association, as trustee (the “Trustee”), as supplemented by the Twenty-Seventh Supplemental Indenture, dated December 11, 2023, between the Company and the Trustee (the “Supplemental Indenture” and, the Base Indenture as so supplemented, the “Indenture”).
The Notes will bear interest at a rate of 3.375% per year. Interest on the Notes is payable on December 11 of each year, commencing on December 11, 2024. The Notes will mature on December 11, 2028.
The Company may redeem the Notes at its option, in whole, but not in part, for cash, at any time prior to their maturity at a price equal to 100% of the outstanding principal amount of the Notes, plus accrued and unpaid interest to, but not including, the redemption date, if certain tax events occur that would obligate the Company to pay additional amounts as described in the Indenture. In addition, prior to September 11, 2028, the Company may redeem the Notes at the Company’s option for cash, any time in whole or from time to time in part, at a redemption price that includes accrued and unpaid interest and the applicable make-whole premium, as specified in the Indenture. However, no make-whole premium will be paid for redemption of the Notes on or after September 11, 2028.
The Company expects to receive net proceeds of approximately €597 million (or $649 million based on an exchange rate of €1 to $1.0878 on December 1, 2023, as published by the U.S. Federal Reserve Board), after deducting the underwriting discount and the Company’s estimated expenses related to the Offering. The Company intends to use the net proceeds from the Offering for general corporate purposes.
The Company may issue additional debt from time to time pursuant to the Indenture. The Indenture contains covenants that limit the Company’s ability to, among other things, incur certain liens securing indebtedness, engage in certain sale and leaseback transactions, and enter into certain consolidations, mergers, conveyances, transfers or leases of all or substantially all of the Company’s assets. Subject to certain limitations, in the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of the Notes below investment grade rating by both Moody’s Investors’ Services, Inc. and Standard & Poor’s Ratings Services within a specified time period, the Company will be required to make an offer to purchase the Notes at a price equal to 101% of the principal amount of the Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.
The foregoing description of the Underwriting Agreement, the Base Indenture and the Supplemental Indenture does not purport to be complete and is qualified in its entirety by reference to the full text of such documents, which are filed as Exhibits 1.1, 4.1 and 4.2 hereto, respectively, and incorporated herein by reference.
ITEM 2.03 | CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT |
The information set forth in Item 1.01 above with respect to the Notes is hereby incorporated by reference into this Item 2.03, insofar as it relates to the creation of a direct financial obligation.
ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Stryker Corporation | ||||||
(Registrant) | ||||||
Dated: December 11, 2023 | By: | |||||
Name: | Glenn S. Boehnlein | |||||
Title: | Vice President, Chief Financial Officer |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
12/11/28 | ||||
9/11/28 | ||||
12/11/24 | ||||
Filed on / For Period end: | 12/11/23 | |||
12/6/23 | 424B5, FWP | |||
12/1/23 | 144, 4, S-3ASR | |||
1/15/10 | 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/14/24 Stryker Corp. 10-K 12/31/23 105:14M 12/11/23 Stryker Corp. 8-A12B 1:16K Donnelley … Solutions/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/15/10 Stryker Corp. 8-K:1,2,8,9 1/12/10 6:769K Donnelley … Solutions/FA |